Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
COMPASS Pathways has raised $200.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2026.
COMPASS Pathways's investors include RA Capital Management, Founders Fund, Vivo Capital, Catalio Capital Management, Perceptive Advisors.
COMPASS Pathways is headquartered in Altrincham, United Kingdom.
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
COMPASS Pathways is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"COMPASS Pathways — Funding & Investors." VCBacked, February 26, 2026, https://www.vcbacked.co/company/compass-pathways. Accessed August 13, 2026.
VCBacked. (2026). COMPASS Pathways — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/compass-pathways
{{cite web |title=COMPASS Pathways — Funding & Investors |url=https://www.vcbacked.co/company/compass-pathways |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated